author-photo

Darren R. Shafren

University of Newcastle

71

Papers

1929

Citations

Citation Trend

Filter By

Papers (48) Sort By

Journal Conference Others

Abstract CT139: Intratumoral oncolytic virus V937 in combination with pembrolizumab (pembro) in patients (pts) with advanced melanoma: Updated results from the phase 1b CAPRA study

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus

2018 Molecular Therapy - Oncolytics
Show All
- Source
- Cite
- Save
Citations (32)
Abstract CT114: The MITCI (Phase 1b) study: A novel immunotherapy combination of intralesional Coxsackievirus A21 and systemic ipilimumab in advanced melanoma patients with or without previous immune checkpoint therapy treatment

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (15)
Abstract CT026: Phase 1b study of intratumoral Coxsackievirus A21 (CVA21) and systemic pembrolizumab in advanced melanoma patients: Interim results of the CAPRA clinical trial

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)
Abstract CT115: Phase 1b KEYNOTE 200 (STORM study): A study of an intravenously delivered oncolytic virus, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Activity of a novel immunotherapy combination of intralesional Coxsackievirus A21 and systemic ipilimumab in advanced melanoma patients previously treated with anti-PD1 blockade therapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Intravenous coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients: phase Ib KEYNOTE 200 study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract CT021: Phase Ib study of a novel immunotherapy combination therapy of intralesional coxsackievirus A21 and systemic ipilimumab in patients with advanced melanoma

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Abstract CT053: Intratumoral coxsackievirus A21 increases immune-cell infiltrates and upregulates immune-checkpoint molecules in the tumor microenvironment of advanced melanoma patients: phase II CALM extension study

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)